Literature DB >> 35606624

The microbiological spectrum, antimicrobial resistance pattern, and visual outcomes of endogenous endophthalmitis in West Virginia 2009-2019.

Chang Sup Lee1,2, Jeffrey Desilets1,3, Wei Fang4, David M Hinkle5,6.   

Abstract

PURPOSE: To report the microbiological spectrum, antimicrobial resistance patterns, and visual outcomes in patients with endogenous endophthalmitis (EE).
METHODS: This was a retrospective study of 50 patients with culture-positive EE managed in a tertiary referral center between October 2009 and 2019. Clinical, microbiology analysis, and antimicrobial resistance were reviewed. A multivariable linear regression analysis was used for identifying risk factors associated with worse visual outcomes.
RESULTS: Fifty organisms were identified, 62% bacterial and 38% fungal. The most common bacterial organism was Staphylococcus aureus (75% methicillin resistant), and Candida was the most common fungal species. Multidrug resistance was observed in methicillin-resistant Staphylococcus aureus (MRSA) isolates against clindamycin, daptomycin, and fluoroquinolones. The distributions of the final visual acuity (VA) between the bacterial and fungal groups were significantly different, and the visual outcomes in the bacterial group tended to be worse (p = 0.01). The distributions of enucleation status were significantly higher in bacterial EE (35%) than fungal EE (5.3%) (p = 0.02). Results from the multivariable linear regression analysis revealed that older age was significantly associated with worse visual outcome (coef = 0.03; p = 0.02), while fungal infections were associated with better outcomes (coef = - 0.87; p = 0.01). Intravenous drug use (coef = 0.87; p = 0.054) was a marginally significant factor associated with worse visual outcomes.
CONCLUSION: There was a higher prevalence of bacterial organisms than fungal species among EE. Bacterial EE was associated with worse visual outcomes and higher enucleation rates than fungal EE. Multidrug resistance was prevalent among MRSA isolates. Older age and intravenous drug use may be factors associated with poor prognosis.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Antimicrobial resistance; Endogenous; Endophthalmitis

Year:  2022        PMID: 35606624     DOI: 10.1007/s10792-022-02315-4

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  25 in total

Review 1.  Endogenous endophthalmitis.

Authors:  S P Chee; A Jap
Journal:  Curr Opin Ophthalmol       Date:  2001-12       Impact factor: 3.761

Review 2.  People and eyes: statistical approaches in ophthalmology.

Authors:  I E Murdoch; S S Morris; S N Cousens
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

3.  An Outbreak of Endogenous Fungal Endophthalmitis Among Intravenous Drug Abusers in New England.

Authors:  Aubrey R Tirpack; Jay S Duker; Caroline R Baumal
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

4.  Characteristics and Outcomes of Endogenous Endophthalmitis: Eight-Year Experience at a Tertiary Care Center.

Authors:  Bobeck S Modjtahedi; Avni P Finn; Scott M Barb; Matthew J MacLachlan; Tavé van Zyl; Thanos D Papakostas; Dean Eliott
Journal:  Ophthalmol Retina       Date:  2018-09-06

5.  Changes in the clinical features and prognostic factors of endogenous endophthalmitis: fifteen years of clinical experience in Korea.

Authors:  Suhwan Lee; Taewoong Um; Soo Geun Joe; Jong-Uk Hwang; June-Gone Kim; Young Hee Yoon; Joo Yong Lee
Journal:  Retina       Date:  2012-05       Impact factor: 4.256

6.  Endogenous endophthalmitis: a 10-year review of culture-positive cases in northern China.

Authors:  Han Zhang; Zheli Liu
Journal:  Ocul Immunol Inflamm       Date:  2010-04       Impact factor: 3.070

7.  Endogenous endophthalmitis: 10-year experience at a tertiary referral centre.

Authors:  P P Connell; E C O'Neill; D Fabinyi; F M A Islam; R Buttery; M McCombe; R W Essex; E Roufail; B Clark; D Chiu; W Campbell; P Allen
Journal:  Eye (Lond)       Date:  2010-10-22       Impact factor: 3.775

8.  Endogenous endophthalmitis caused by methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Thomas Ness; Christian Schneider
Journal:  Retina       Date:  2009-06       Impact factor: 4.256

Review 9.  Metastatic bacterial endophthalmitis: a contemporary reappraisal.

Authors:  M J Greenwald; L G Wohl; C H Sell
Journal:  Surv Ophthalmol       Date:  1986 Sep-Oct       Impact factor: 6.048

10.  Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes.

Authors:  Vivian Schiedler; Ingrid U Scott; Harry W Flynn; Janet L Davis; Matthew S Benz; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2004-04       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.